Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q1 EPS of ($2.13), $1.89 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.